HOWL Q2 2022 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOWLWerewolf Therapeutics, Inc.

$41M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M

Gross Profit

-$10M-234.8% margin

Operating Income

-$15M-360.9% margin

Net Income

-$15M-351.8% margin

EPS (Diluted)

$-0.52

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$303,000

Free Cash Flow

-$1M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$175M

Total Liabilities

$45M

Stockholders' Equity

$130M

Cash & Equivalents

$146M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$0	—
Gross Profit	-$10M	$0	—
Operating Income	-$15M	-$11M	-36.7%
Net Income	-$15M	-$11M	-33.6%